SDG3 Newsletter: Diseases

To kick off 2025, we've mainly been discussing the third and fourth WHO targets for ensuring good health and well-being for all. These are to combat communicable diseases and to reduce mortality from non-communicable diseases (NCDs).
SDG3 Newsletter: Diseases
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Use these links to navigate to a section! This newsletter covers:

Sickle Cell Disease and its impact on the Black community

Check out this interesting  blog written recently by members of Springer Nature's Black Employee Network. They focus on social, medical and policy approaches to improve the lives of those within the Black community affected by sickle cell disease.

Rare Disease Day

This Friday 28 February is Rare Disease Day. Read this blog to discover relevant journal articles, clinical trials, blogs and Q&As with researchers.

World Cancer Day: person-centred care

Read this blog on the new new 2025-2027 theme for World Cancer Day, ‘United by Unique.’ Here you can find related blogs, articles, Collections and clinical trials.

Don't forget to check out this blog on the highly-accessed Collection, Fibrosis and Cancer Intersection, published in Journal of Translational Medicine

Meet the Editors of Implementation Science Communications

Read Dr Elvin Geng's recent Q&A announcing his position as co-Editor-in-Chief of Implementation Science Communications. As an infectious disease physician involved in the public health HIV response and in AIDS research, Dr Geng discusses the current context in the US and the implications it may have for the global HIV response.

You can also read this Q&A for World AIDS Day, where Dr Aaloke Mody, Associate Editor, shares his experiences working in the fields of HIV and AIDS.

A history of Journal of Cannabis Research

Explore this blog on the history of Journal of Cannabis Research to learn about the use of medical cannabis in treating disease and improving symptoms.

HPV vaccination progress

Source: free Adobe Stock image

HPV Awareness Day is next week (4 March). Check out this blog that explains HPV vaccination progress and outlines areas for improvement in vaccination programmes.

Maternal and Neonatal Health webinar: sign up now

On 19 March we are hosting a free webinar on “Implementation of Evidence-Based Practices for Improving Maternal and Neonatal Health”. This webinar has some really interesting speakers, click the link to learn more and register.

Get involved! 

Thank you to everyone who contributed to this newsletter. If you are a researcher or colleague who would like to be involved with our SDG3 initiatives, get in touch. To be notified of future SDG3 newsletters, follow me, Alice Coe, on Research Communities. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Go to the profile of Louis Gautier
10 months ago

This is all really cool, Alice! I've followed you so I can see all the new ones you send out :)

Go to the profile of Tamara May
9 months ago

Thanks for this, Alice. Great to see all the hard work being done by our Publishers, Editors, and Authors to help achieve the SDG3 targets!

Go to the profile of Alice Coe
9 months ago

Read our 2024 round-up newsletter here!

Follow the Topic

Public Health
Life Sciences > Health Sciences > Public Health
Reproductive Medicine
Life Sciences > Health Sciences > Clinical Medicine > Reproductive Medicine
Disease Prevention
Life Sciences > Health Sciences > Public Health > Health Promotion and Disease Prevention > Disease Prevention
Diseases
Life Sciences > Health Sciences > Clinical Medicine > Diseases
SDG 3: Good Health & Wellbeing
Research Communities > Community > Sustainability > UN Sustainable Development Goals (SDG) > SDG 3: Good Health & Wellbeing

Your space to connect: The Primary immunodeficiency disorders Hub

A new Communities’ space to connect, collaborate, and explore research on Clinical Medicine, Immunology, and Diseases!

Continue reading announcement

Related Collections

With Collections, you can get published faster and increase your visibility.

Non-psychotropic cannabinoids in drug discovery and their therapeutic potential

The exploration of non-psychotropic cannabinoids is crucial for advancing the scientific understanding of their therapeutic potential and applications in drug discovery. As cannabinoid research continues to evolve, we are uncovering the multiple ways in which these compounds, including CBD (cannabidiol), interact either with cannabinoid receptors or with other targets to impact human health. The importance of this research is underscored by the growing interest in medical cannabis, particularly as it relates to cannabinoid therapy for various conditions.

Significant advances have already been made in this field. For instance, recent studies have demonstrated the efficacy of non-psychotropic cannabinoids in managing chronic pain, CNS diseases, inflammatory disorders and iperproliferative diseases, showcasing their potential as alternative therapies to conventional pharmaceuticals. Furthermore, the ongoing investigation into cannabinoid pharmacology has shed light on the mechanisms of action of these compounds, paving the way for more targeted and effective treatments. These breakthroughs not only contribute to the scientific community but also provide hope for patients seeking relief from debilitating conditions.

We invite researchers to contribute to this Special Collection. Topics of interest include but are not limited to:

• Extraction and analysis of non-psychotropic cannabinoids

• Biological activity and mechanisms of action of non-psychotropic cannabinoids

• Therapeutic applications of CBD

• Cannabinoid pharmacology and receptor interaction

• Drug discovery strategies involving cannabinoids

• Clinical trials of cannabinoid therapies

• Social implications of cannabinoid use

• Innovations in cannabinoid applications.

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being and SDG 9, Industry & Innovation.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Feb 14, 2026

Healthcare professionals and cannabis: knowledge, attitudes, and training

Journal of Cannabis Research is calling for submissions to our Collection on the latest advancements in “Healthcare professionals and cannabis: knowledge, attitudes, and training.” As the use of cannabis expands and societal attitudes continue to evolve, the role of healthcare professionals in understanding, recommending, and managing cannabis-related therapies and behaviors becomes increasingly vital. This Collection aims to explore the multifaceted interactions between healthcare providers and cannabis.

We invite original research, reviews, and perspectives on the following themes:

• Knowledge: Assessments of perceived and objective knowledge levels of healthcare professionals about cannabis pharmacology, therapeutic benefits, and potential risks.

• Awareness: Evaluations of awareness regarding current evidence-based guidelines and best practices for cannabis use in both clinical and non-clinical settings.

• Attitudes and perceptions: healthcare providers’ beliefs and biases toward cannabis use, both medical and non-medical – and the potential influence of attitudes and personal experience on decision-making, patient interactions, and public health advisories.

• Education: development and assessment of educational programs and curricula focused on cannabis in medical and public health education.

• Training: identifying and overcoming gaps in cannabis-related training.

• Clinical practices: the integration of cannabis into various medical specialties and clinical practices.

• Patient care and communication: insights into how healthcare providers discuss cannabis use with patients, including strategies for effective communication and patient education on both medical and non-medical use.

• Policy and regulation: the role of healthcare professionals in shaping and responding to cannabis policy changes affecting both medical and non-medical contexts.

• Interdisciplinary approaches: collaborative efforts between different healthcare disciplines in managing cannabis-related patient care and public health initiatives.

This Special Collection serves as a platform for healthcare professionals, researchers, educators, policymakers, and public health experts to share their insights and advancements. By bringing together diverse perspectives and findings, we aim to enhance the collective understanding of how cannabis intersects with healthcare practice and public health, ultimately improving patient outcomes, informing public health strategies, and shaping future educational and policy initiatives.

This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being, SDG 4, Quality Education, and SDG 10, Reduced Inequalities.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Feb 03, 2026